Panlong Pharmaceutical

Shaanxi Panlong Pharmaceutical Group is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM) with a primary focus on orthopedics. The company is best known for its flagship product, Panlong Qi Pain Relief Plaster (Panlong Qi Pian), which holds a significant market share in China for the treatment of rheumatic and bone-related ailments. Panlong Pharmaceutical operates an integrated value chain that includes medicinal herb cultivation, modern pharmaceutical manufacturing, and a nationwide distribution network. In addition to its TCM portfolio, the company produces chemical generic drugs, medical devices, and health supplements targeting pain management and general wellness. Listed on the Shenzhen Stock Exchange, the group continues to expand its industrial footprint through the modernization of traditional formulas and the development of new drug delivery systems.